Aki Yoshida

3.9k total citations
115 papers, 3.0k citations indexed

About

Aki Yoshida is a scholar working on Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aki Yoshida has authored 115 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 29 papers in Rheumatology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aki Yoshida's work include Sarcoma Diagnosis and Treatment (21 papers), Osteoarthritis Treatment and Mechanisms (18 papers) and RNA Interference and Gene Delivery (12 papers). Aki Yoshida is often cited by papers focused on Sarcoma Diagnosis and Treatment (21 papers), Osteoarthritis Treatment and Mechanisms (18 papers) and RNA Interference and Gene Delivery (12 papers). Aki Yoshida collaborates with scholars based in Japan, United States and United Kingdom. Aki Yoshida's co-authors include Toshifumi Ozaki, Keiichiro Nishida, Toshiyuki Kunisada, Takayuki Furumatsu, Hajime Inoue, Yuki Morimoto, Akira Kawai, Takamitsu Komiyama, Mamoru Ouchida and Tomohiro Fujiwara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Aki Yoshida

110 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aki Yoshida Japan 33 1.3k 657 561 552 525 115 3.0k
Takehiro Kimura Japan 33 980 0.8× 741 1.1× 379 0.7× 560 1.0× 478 0.9× 197 3.7k
Jun Qi China 28 873 0.7× 475 0.7× 701 1.2× 348 0.6× 530 1.0× 195 2.7k
Jin Kim South Korea 32 1.4k 1.1× 461 0.7× 233 0.4× 593 1.1× 449 0.9× 113 3.3k
Jianliu Wang China 30 1.0k 0.8× 301 0.5× 276 0.5× 543 1.0× 577 1.1× 319 3.4k
Zhaoming Ye China 34 1.1k 0.8× 535 0.8× 892 1.6× 779 1.4× 521 1.0× 194 3.4k
Pauline M. Chou United States 31 1.2k 0.9× 399 0.6× 750 1.3× 603 1.1× 503 1.0× 98 3.1k
Elaine Unemori United States 37 1.1k 0.9× 363 0.6× 653 1.2× 641 1.2× 1.1k 2.1× 66 5.7k
Surapol Issaragrisil Thailand 30 991 0.8× 863 1.3× 221 0.4× 733 1.3× 235 0.4× 155 4.5k
John Slavin Australia 30 997 0.8× 463 0.7× 831 1.5× 1.1k 2.0× 321 0.6× 78 3.5k
Xun Ye China 26 742 0.6× 632 1.0× 365 0.7× 513 0.9× 294 0.6× 157 2.6k

Countries citing papers authored by Aki Yoshida

Since Specialization
Citations

This map shows the geographic impact of Aki Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Yoshida more than expected).

Fields of papers citing papers by Aki Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aki Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Yoshida. The network helps show where Aki Yoshida may publish in the future.

Co-authorship network of co-authors of Aki Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Aki Yoshida. A scholar is included among the top collaborators of Aki Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aki Yoshida. Aki Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasei, Joe, Ryuichi Nakahara, Koichi Takeuchi, et al.. (2025). Comparative analysis of a standard (GPT-4o) and reasoning-enhanced (o1 pro) large language model on complex clinical questions from the Japanese orthopaedic board examination. Journal of Orthopaedic Science. 30(3). 565–568. 1 indexed citations
2.
Nishida, Keiichiro, Aki Yoshida, Ryuichi Nakahara, et al.. (2025). LRP4 and Agrin Are Modulated by Cartilage Degeneration and Involved in β-Catenin Signaling in Human Articular Chondrocytes. International Journal of Molecular Sciences. 26(3). 1007–1007.
3.
Hasei, Joe, Ryuichi Nakahara, Yujiro Otsuka, et al.. (2024). The Three-Class Annotation Method Improves the AI Detection of Early-Stage Osteosarcoma on Plain Radiographs: A Novel Approach for Rare Cancer Diagnosis. Cancers. 17(1). 29–29. 2 indexed citations
4.
Uotani, Koji, Tomohiro Fujiwara, Koji Ueda, et al.. (2024). Identification of ENO‐1 positive extracellular vesicles as a circulating biomarker for monitoring of Ewing sarcoma. Cancer Science. 115(11). 3660–3671. 3 indexed citations
5.
6.
Nishida, Keiichiro, Yuka Gion, Aki Yoshida, et al.. (2022). CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. Inflammation Research. 71(2). 215–226. 4 indexed citations
7.
Fujiwara, Tomohiro, Mohamed A. Yakoub, Andrew Chandler, et al.. (2021). CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment. Molecular Cancer Therapeutics. 20(8). 1388–1399. 157 indexed citations
8.
Nishida, Keiichiro, et al.. (2021). Adipose-Derived Extract Suppresses IL-1β-Induced Inflammatory Signaling Pathways in Human Chondrocytes and Ameliorates the Cartilage Destruction of Experimental Osteoarthritis in Rats. International Journal of Molecular Sciences. 22(18). 9781–9781. 5 indexed citations
9.
Saito, Taichi, et al.. (2021). Effect of difference in fixation methods of tendon graft and the microfracture procedure on tendon-bone junction healing. JSES International. 6(1). 155–166. 1 indexed citations
10.
Yamada, Daisuke, Masahiro Nakamura, Tomoka Takao, et al.. (2021). Induction and expansion of human PRRX1+ limb-bud-like mesenchymal cells from pluripotent stem cells. Nature Biomedical Engineering. 5(8). 926–940. 36 indexed citations
11.
Tazawa, Hiroshi, Joe Hasei, Yasuaki Yamakawa, et al.. (2021). Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer Chemotherapy and Pharmacology. 88(3). 513–524. 13 indexed citations
12.
Takabatake, Kiyofumi, Hidetsugu Tsujigiwa, Aki Yoshida, et al.. (2021). A Pilot Study of Seamless Regeneration of Bone and Cartilage in Knee Joint Regeneration Using Honeycomb TCP. Materials. 14(23). 7225–7225. 1 indexed citations
13.
Nishida, Keiichiro, et al.. (2021). RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis. PLoS ONE. 16(7). e0254268–e0254268. 6 indexed citations
14.
Fujiwara, Tomohiro, Aki Yoshida, Koji Uotani, et al.. (2021). Liquid Biopsy Targeting Monocarboxylate Transporter 1 on the Surface Membrane of Tumor-Derived Extracellular Vesicles from Synovial Sarcoma. Cancers. 13(8). 1823–1823. 9 indexed citations
15.
Yamada, Daisuke, Masahiro Nakamura, Aki Yoshida, et al.. (2020). PRRX1 promotes malignant properties in human osteosarcoma. Translational Oncology. 14(1). 100960–100960. 10 indexed citations
16.
Noguchi, Yoshihiro, Yuta Hayashi, Aki Yoshida, et al.. (2016). Pharmacoepidemiological Examination for the Safety of the Oral laxatives in the Elderly Patients. 18(3). 179–185. 1 indexed citations
17.
Fujiwara, Tomohiro, Toshiyuki Kunisada, Ken Takeda, et al.. (2014). MicroRNAs in Soft Tissue Sarcomas: Overview of the Accumulating Evidence and Importance as Novel Biomarkers. BioMed Research International. 2014. 1–15. 23 indexed citations
18.
Hasei, Joe, Tsuyoshi Sasaki, Hiroshi Tazawa, et al.. (2013). Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells. Molecular Cancer Therapeutics. 12(3). 314–325. 53 indexed citations
19.
Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2011). Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas. Clinical Cancer Research. 17(7). 1828–1838. 43 indexed citations
20.
Nishida, Keiichiro, Akira Shimizu, Hideyuki Doi, et al.. (2008). Intra-articular injection of interleukin-4 decreases nitric oxide production by chondrocytes and ameliorates subsequent destruction of cartilage in instability-induced osteoarthritis in rat knee joints. Osteoarthritis and Cartilage. 16(7). 764–771. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takehiro Kimura Breakdown of academic impact, for papers by Jun Qi Breakdown of academic impact, for papers by Jin Kim Breakdown of academic impact, for papers by Jianliu Wang Breakdown of academic impact, for papers by Zhaoming Ye Breakdown of academic impact, for papers by Pauline M. Chou Breakdown of academic impact, for papers by Elaine Unemori Breakdown of academic impact, for papers by Surapol Issaragrisil Breakdown of academic impact, for papers by John Slavin Breakdown of academic impact, for papers by Xun Ye
Rankless by CCL
2026